Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,900 | 18,200 | 113,000 | 97,200 | 68,100 |
| Depreciation Amortization | 27,500 | 13,500 | 54,800 | 41,100 | 27,100 |
| Income taxes - deferred | 1,000 | -2,500 | -5,600 | 1,000 | 3,700 |
| Accounts receivable | -19,600 | -3,300 | 5,300 | 800 | -4,000 |
| Other Working Capital | -49,700 | -15,800 | 5,800 | -23,600 | -36,500 |
| Other Operating Activity | 41,800 | 19,800 | 39,800 | 17,500 | 16,100 |
| Operating Cash Flow | $58,900 | $29,900 | $213,100 | $134,000 | $74,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -400 | N/A | -52,100 | -700 | -600 |
| PPE Investments | 53,300 | 64,900 | -49,800 | -37,700 | -25,000 |
| Net Acquisitions | N/A | N/A | -37,000 | -9,600 | -9,600 |
| Purchase Of Investment | 1,900 | 1,400 | -3,900 | -3,000 | -1,800 |
| Sale Of Investment | 23,400 | 16,600 | 1,400 | N/A | N/A |
| Purchase Sale Intangibles | -400 | N/A | -5,500 | -1,000 | -1,000 |
| Other Investing Activity | -400 | 0 | -6,000 | -1,500 | -1,000 |
| Investing Cash Flow | $77,800 | $82,900 | $-147,400 | $-52,500 | $-38,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 97,000 | 13,200 | 57,300 | 44,200 | 30,300 |
| Debt Repayment | -22,500 | -20,200 | -85,200 | N/A | -55,900 |
| Common Stock Issued | 35,300 | 6,200 | 38,700 | 32,600 | 20,900 |
| Common Stock Repurchased | -214,800 | -100,000 | -130,900 | -107,200 | -59,800 |
| Other Financing Activity | 9,300 | 2,200 | 12,000 | -59,400 | 10,800 |
| Financing Cash Flow | $-95,700 | $-98,600 | $-108,100 | $-89,800 | $-53,700 |
| Exchange Rate Effect | 5,400 | 6,900 | 1,400 | 1,200 | -700 |
| Beginning Cash Position | 141,800 | 141,800 | 182,800 | 182,800 | 182,800 |
| End Cash Position | 188,200 | 162,900 | 141,800 | 175,700 | 164,900 |
| Net Cash Flow | $46,400 | $21,100 | $-41,000 | $-7,100 | $-17,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,900 | 29,900 | 213,100 | 134,000 | 74,500 |
| Capital Expenditure | -20,700 | -9,100 | -57,000 | -43,100 | -27,400 |
| Free Cash Flow | 38,200 | 20,800 | 156,100 | 90,900 | 47,100 |